Maruyama W - Search Results

1

An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells.

Akao Y, Maruyama W, Yi H, Shamoto-Nagai M, Youdim MB, Naoi M. Akao Y, et al. Among authors: maruyama w. Neurosci Lett. 2002 Jun 28;326(2):105-8. doi: 10.1016/s0304-3940(02)00332-4. Neurosci Lett. 2002. PMID: 12057839

2

Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells.

Maruyama W, Oya-Ito T, Shamoto-Nagai M, Osawa T, Naoi M. Maruyama W, et al. Neurosci Lett. 2002 Mar 15;321(1-2):29-32. doi: 10.1016/s0304-3940(01)02490-9. Neurosci Lett. 2002. PMID: 11872249

3

Tribute to professor Toshiharu Nagatsu.

Naoi M, Parvez H, Maruyama W, Collins MA, Youdim MB. Naoi M, et al. Among authors: maruyama w. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):563-4. doi: 10.1016/s0892-0362(02)00262-3. Neurotoxicol Teratol. 2002. PMID: 12200186 No abstract available.

4

Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.

Naoi M, Maruyama W, Akao Y, Yi H. Naoi M, et al. Among authors: maruyama w. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):579-91. doi: 10.1016/s0892-0362(02)00211-8. Neurotoxicol Teratol. 2002. PMID: 12200189 Review.

5

Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes.

Maruyama W, Akao Y, Carrillo MC, Kitani K, Youdium MB, Naoi M. Maruyama W, et al. Neurotoxicol Teratol. 2002 Sep-Oct;24(5):675-82. doi: 10.1016/s0892-0362(02)00221-0. Neurotoxicol Teratol. 2002. PMID: 12200198 Review.

6

Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan.

Akao Y, Maruyama W, Shimizu S, Yi H, Nakagawa Y, Shamoto-Nagai M, Youdim MB, Tsujimoto Y, Naoi M. Akao Y, et al. Among authors: maruyama w. J Neurochem. 2002 Aug;82(4):913-23. doi: 10.1046/j.1471-4159.2002.01047.x. J Neurochem. 2002. PMID: 12358797 Free article.

7

Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.

Tanaka M, Borgeld HJ, Zhang J, Muramatsu S, Gong JS, Yoneda M, Maruyama W, Naoi M, Ibi T, Sahashi K, Shamoto M, Fuku N, Kurata M, Yamada Y, Nishizawa K, Akao Y, Ohishi N, Miyabayashi S, Umemoto H, Muramatsu T, Furukawa K, Kikuchi A, Nakano I, Ozawa K, Yagi K. Tanaka M, et al. Among authors: maruyama w. J Biomed Sci. 2002;9(6 Pt 1):534-41. doi: 10.1159/000064726. J Biomed Sci. 2002. PMID: 12372991

8

Cell death in Parkinson's disease.

Maruyama W, Naoi M. Maruyama W, et al. J Neurol. 2002 Sep;249 Suppl 2:II6-10. doi: 10.1007/s00415-002-1202-6. J Neurol. 2002. PMID: 12375057

9

Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor.

Maruyama W, Weinstock M, Youdim MB, Nagai M, Naoi M. Maruyama W, et al. Neurosci Lett. 2003 May 8;341(3):233-6. doi: 10.1016/s0304-3940(03)00211-8. Neurosci Lett. 2003. PMID: 12697291

10

An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.

Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T. Shamoto-Nagai M, et al. Among authors: maruyama w. J Neurosci Res. 2003 Nov 15;74(4):589-97. doi: 10.1002/jnr.10777. J Neurosci Res. 2003. PMID: 14598303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters